Patents by Inventor Matthieu Perreau

Matthieu Perreau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9146236
    Abstract: This disclosure relates to methods for differentiating between mammals having active and latent Tuberculosis disease, by determining the percentage of polyfunctional CD4+ T-cells expressing TNF-alpha, IFN-gamma, and IL-2, or by determining expression of IL-17.
    Type: Grant
    Filed: December 22, 2011
    Date of Patent: September 29, 2015
    Inventors: Giuseppe Pantaleo, Alexandre Harari, Matthieu Perreau
  • Publication number: 20130338059
    Abstract: This disclosure relates to methods for differentiating between mammals having active and latent Tuberculosis disease, by determining the percentage of polyfunctional CD4+ T-cells expressing TNF-alpha, IFN-gamma, and IL-2, or by determining expression of IL-17.
    Type: Application
    Filed: December 22, 2011
    Publication date: December 19, 2013
    Applicant: Centre Hospitalier Universitaire Vaudois
    Inventors: Giuseppe Pantaleo, Alexandre Harari, Matthieu Perreau